Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2005
11/30/2005EP1600496A1 Method of inhibiting formation of volatile aldehydes and/or decomposition of fatty acids and use thereof
11/30/2005EP1600210A1 Charged microspheres
11/30/2005EP1600188A2 Flow restricting orifice device having multiple channels between multiple coiled layers for drug delivery
11/30/2005EP1600187A2 Orifice device having multiple channels with varying flow rates for drug delivery
11/30/2005EP1600170A1 Sustained-release pharmaceutical composition for lung administration
11/30/2005EP1600157A1 Enteric sustained-release fine particles for tamsulosin or its salt and process for producing the same
11/30/2005EP1600155A1 The use of polyols in combating yeast infection and polyol preparations for said use
11/30/2005EP1600154A1 Osmotic extended-release dosage form
11/30/2005EP1600153A1 Slow-release pharmaceutical composition allowing to monitor drug release
11/30/2005EP1600143A1 SKIN PREPARATION FOR EXTERNAL USE CHARACTERIZED BY CONTAINING SUGAR DERIVATIVE OF a,a-TREHALOSE
11/30/2005EP1599233A2 Sterilization of beclomethasone drug particles for pulmonary delivery
11/30/2005EP1599229A2 Implantable or insertable medical devices containing miscible polymer blends for controlled delivery of a therapeutic agent
11/30/2005EP1599212A2 Combination therapy for the treatment of immunoinflammatory disorders
11/30/2005EP1599209A2 Inhalation composition
11/30/2005EP1599193A2 Method for treating hypothyroidism
11/30/2005EP1599192A2 Pearlescent film coating systems and substrates coated therewith
11/30/2005EP1599191A2 Pharmaceutical composition of alendronic acid, salts or esters thereof, and a process for its preparation
11/30/2005EP1599190A2 Controlled release modifying complex and pharmaceutical compositions thereof
11/30/2005EP1599189A1 Control release formulation containing a hydrophobic material as the sustained release agent
11/30/2005EP1599188A2 POWDER FORMULATIONS OF RECOMBINANT STAPHYLOCOCCAL, ENTEROTOXIN B (<SB>R</SB>SEB) MADE BY ATMOSPHERIC SPRAY-FREEZE DRYING FOR IMPROVED VACCINATION
11/30/2005EP1599187A2 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
11/30/2005EP1599186A1 Transmucosal drug delivery system
11/30/2005EP1599185A1 Dosage form having a saccharide matrix
11/30/2005EP1599184A1 Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
11/30/2005EP1599183A2 Method of drug loading in liposomes by gradient
11/30/2005EP1599173A2 Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
11/30/2005EP1423093A4 Bifunctional-modified hydrogels
11/30/2005EP1392337B1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
11/30/2005EP1313511B1 Testosterone ester formulation for human use
11/30/2005EP1289534B1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/30/2005EP1267831B1 New self emulsifying drug delivery system
11/30/2005EP1263451B1 Hard gelatine capsules containing sustained-release plant extracts and method for production thereof
11/30/2005EP1257299B9 Radioactive therapeutic liposomes
11/30/2005EP1246668B1 An rapid acting freeze dired oral pharmaceutical composition for treating migraine
11/30/2005EP1227794B1 Method for encapsulating proteins or peptides in liposomes
11/30/2005EP1223985B1 Dialysis solution including polyglycol osmotic agent
11/30/2005EP1221941A4 Powder pharmaceutical formulations
11/30/2005EP1207809A4 Metering and packaging of controlled release medication
11/30/2005EP1178793B1 Stable solid pharmaceutical compositions containing enalapril maleate
11/30/2005EP1173153B1 Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants
11/30/2005EP1159278B1 Inhibitors of aspartyl protease
11/30/2005EP1148883B1 Use of tricyclic antidepressants for treatment of headache
11/30/2005EP1140010B1 Composition and method of sequestration of skin irritants.
11/30/2005EP1095162B1 Archiving of vectors
11/30/2005EP1089715B1 Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
11/30/2005EP1079832B1 Use of vitamin pp compounds
11/30/2005EP1003487B1 Pharmaceutical formulation with controlled release of active substances
11/30/2005EP0831933B1 Use of emulsions comprising lipid encapsulated liquid fluorocarbons for in vivo targeted diagnostic procedures
11/30/2005CN2742962Y Wind expelling damage dispelling plaster
11/30/2005CN1703250A Plaster
11/30/2005CN1703246A Solution for ungual and peri-ungual application
11/30/2005CN1703233A Methods and compositions for preventing oxidative degradation of proteins
11/30/2005CN1703215A Stabilized pharmaceutical preparation comprising an amorphous active substance
11/30/2005CN1703209A Method for cardioprotection and neuroprotection by intravenous administration of halogenated volatile anesthetics
11/30/2005CN1703206A Plaster for the treatment of dysfunctions and disorders of nail growth
11/30/2005CN1703205A Extended, controlled-release pharmaceutical compositions using charged polymers
11/30/2005CN1703204A Stabilized pharmaceutical composition containing basic excipients
11/30/2005CN1703203A Organoleptically acceptable intraorally disintegrating compositions
11/30/2005CN1703202A Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier
11/30/2005CN1703201A Solid particulate antifungal compositions for pharmaceutical use
11/30/2005CN1703200A Sequestering subunit and related compositions and methods
11/30/2005CN1703199A Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially throug
11/30/2005CN1703198A Depot formulations of arylheterocyclic active agents in the form of a suspension
11/30/2005CN1703197A Injectable depot compositions and uses thereof
11/30/2005CN1703186A Biliquid foam entrapment
11/30/2005CN1703175A Implantation of encapsulated biological materials for treating diseases
11/30/2005CN1703151A Chewing gum and confectionery compositions with encapsulated stain removing agent compositions, and methods of making and using the same
11/30/2005CN1229324C Extraction process of tanshin general phenolic acid and its prepn and use
11/30/2005CN1229148C Adhesion preventing membrane and its preparing method
11/30/2005CN1229138C Method for accelerating rate of mucociliary clearance
11/30/2005CN1229136C Laerimal gland specific emulsions for topical application to ocular tissue
11/30/2005CN1229129C Adhibition ointment for relieving cough
11/30/2005CN1229114C Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
11/30/2005CN1229112C Rapid onset preparation
11/30/2005CN1229111C Sustained release preparations
11/30/2005CN1229110C Ophthalmic compositions containing galactomannan polymers and borate
11/30/2005CN1229097C Long-acting hair fixing mousse
11/30/2005CN1229095C Skin colorant pieces, sets of article composed of such pieces and their storage means, and method therefor
11/30/2005CA2502142A1 Transdermal therapeutic systems
11/29/2005US6969708 Process for the preparation of a high purity composition comprising (7α, 17α)- 17-hydroxy- 7-methyl- 19-nor-17-pregn-5(10)-en-20-yn-3-one
11/29/2005US6969590 Use of a polypeptide for treatment of pruritus in animals
11/29/2005US6969531 Sodium hyaluronate microspheres
11/29/2005US6969530 providing an aqueous mixture containing a loading substance and a gelatin having a low Bloom, mixing to form a primary shell of the gelatin around the loading substance, cooling to agglomerate the gelatin shell, and cooling to form outer shell
11/29/2005US6969529 Comprising a poorly soluble drug having an excipient of vinyl pyrrolidone-vinyl acetate copolymer or polyvinyl pyrrolidone modified by 0.1-5% vinyl acetate which adheres by adsorption to its surface
11/29/2005US6969525 Surgically implanted time release medication for post-surgical treatment of a patient
11/29/2005US6969514 topically administering hyaluronidase
11/29/2005US6969511 Synthetic bulk laxative
11/29/2005US6969508 Buccal aerosol sprays or capsules using polar and non-polar solvent which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect
11/29/2005US6969480 Method of producing structures using centrifugal forces
11/29/2005US6969383 Method for treating severe tinnitus
11/29/2005US6969382 Method and apparatus for treating bodily tissues with medicinal substance
11/29/2005US6968840 Coupling a nebule to an interface of the aerosol generator; reading an identification marker on the nebule; operating the aerosol generator by vibrating the vibratory element according to an operation program based on the information
11/29/2005CA2367013C Metered dose inhaler for fluticasone propionate
11/29/2005CA2355493C Therapeutic compositions comprising excess enantiomer
11/29/2005CA2326660C Method for producing transdermal therapeutic systems by using basic alkali metal salts for converting active agent salts into free bases
11/29/2005CA2308532C Use of bisphosphonates for the treatment of osteogenesis imperfecta
11/29/2005CA2251430C Omeprazole formulation
11/29/2005CA2240462C High-content famciclovir tablets
11/29/2005CA2235346C Composition for transdermal delivery
11/24/2005WO2005111110A1 Non-toxic biodegradable polyurethanes which are intended for the controlled release of pharmaceuticals and for tissue engineering
1 ... 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 ... 2991